Literature DB >> 15588686

Pomegranate extract inhibits Staphylococcus aureus growth and subsequent enterotoxin production.

L C Braga1, J W Shupp, C Cummings, M Jett, J A Takahashi, L S Carmo, E Chartone-Souza, A M A Nascimento.   

Abstract

In Brazil, pomegranate (Punica granatum L. (Punicaceae)) is widely used as a phytotherapeutic agent. This study evaluates the effect of pomegranate extract on Staphylococcus aureus FRI 722 growth and subsequent enterotoxin production. Bacterial susceptibility was determined by tube dilution method and production of enterotoxin was assessed using membrane-over-agar (MOA) plates. At a low extract concentration (0.01% v/v) bacterial growth was delayed, while a higher concentration (1% v/v) eliminated bacterial growth. Most interestingly, a 0.05% (v/v) concentration of extract was found to inhibit Staphylococcal enterotoxin (SE) A production. These data further implicate pomegranate extracts as potential antibacterial therapeutics with the added ability to inhibit enterotoxin production.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15588686     DOI: 10.1016/j.jep.2004.08.034

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  32 in total

1.  Effect of pomegranate seed oil against gentamicin -induced nephrotoxicity in rat.

Authors:  Mohammad Taher Boroushaki; Elham Asadpour; Hamid Reza Sadeghnia; Karim Dolati
Journal:  J Food Sci Technol       Date:  2012-10-23       Impact factor: 2.701

2.  Pomegranate juice may be a potential addition to anti-Behçet armamentarium: a hypothesis.

Authors:  Afshin Borhani Haghighi; Mansooreh Bagheri
Journal:  Clin Rheumatol       Date:  2007-04-04       Impact factor: 2.980

3.  Changes in the composition and architecture of staphylococcal biofilm by nisin.

Authors:  Cleriane Andre; Natan de Jesus Pimentel-Filho; Paulo Mafra de Almeida Costa; Maria Cristina Dantas Vanetti
Journal:  Braz J Microbiol       Date:  2019-08-27       Impact factor: 2.476

4.  Assessment of the antioxidant, antimicrobial and antibiofilm activities of essential oils for potential application of active chitosan films in food preservation.

Authors:  Anouar Mouhoub; Amine Guendouz; Abdeljalil Belkamel; Zainab El Alaoui Talibi; Saad Ibnsouda Koraichi; Cherkaoui El Modafar; Cédric Delattre
Journal:  World J Microbiol Biotechnol       Date:  2022-08-09       Impact factor: 4.253

5.  Antibacterial and antifungal activities of punica granatum peel extracts against oral pathogens.

Authors:  Sh Abdollahzadeh; Ry Mashouf; H Mortazavi; Mh Moghaddam; N Roozbahani; M Vahedi
Journal:  J Dent (Tehran)       Date:  2011-03-31

6.  Antimicrobial activities of pomegranate rind extracts: enhancement by addition of metal salts and vitamin C.

Authors:  Erin M McCarrell; Simon W J Gould; Mark D Fielder; Alison F Kelly; Waffa El Sankary; Declan P Naughton
Journal:  BMC Complement Altern Med       Date:  2008-12-15       Impact factor: 3.659

7.  Anti-microbial activities of pomegranate rind extracts: enhancement by cupric sulphate against clinical isolates of S. aureus, MRSA and PVL positive CA-MSSA.

Authors:  Simon W J Gould; Mark D Fielder; Alison F Kelly; Declan P Naughton
Journal:  BMC Complement Altern Med       Date:  2009-07-27       Impact factor: 3.659

8.  Pomegranate supplementation improves affective and motor behavior in mice after radiation exposure.

Authors:  Melissa S Dulcich; Richard E Hartman
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-15       Impact factor: 2.629

9.  The pomegranate: effects on bacteria and viruses that influence human health.

Authors:  Amy B Howell; Doris H D'Souza
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-20       Impact factor: 2.629

10.  In Vitro and In Vivo Antibacterial Activity of Punica granatum Peel Ethanol Extract against Salmonella.

Authors:  Jang-Gi Choi; Ok-Hwa Kang; Young-Seob Lee; Hee-Sung Chae; You-Chang Oh; Obiang-Obounou Brice; Min-San Kim; Dong-Hwan Sohn; Hun-Soo Kim; Hyun Park; Dong-Won Shin; Jung-Rae Rho; Dong-Yeul Kwon
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-12       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.